Metabolic and endocrinologic complications in beta-thalassemia major: A multicenter study in Tehran

BMC Endocrine Disorders

Volumn 3, Issue , 2003, Pages

  Shamshirsaz, Alireza Abdollah ^a,b   Bekheirnia, Mir Reza ^a,b   Kamgar, Mohammad ^a,b   Pourzahedgilani, Nima ^a   Bouzari, Navid ^a   Habibzadeh, Mohammadreza ^a   Hashemi, Reza ^a   Shamshirsaz, Amir Hooshang Abdollah ^c   Aghakhani, Shahriar ^a   Homayoun, Hooman ^b   Larijani, Bagher ^a,b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Charity Found for Special Diseases   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; DEFEROXAMINE; FERRITIN; LIOTHYRONINE; PARATHYROID HORMONE; PHOSPHATE; THYROTROPIN; THYROXINE;

ADOLESCENT; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BLOOD TRANSFUSION; BONE DENSITY; BONE MINERAL; CALCIUM BLOOD LEVEL; CALCIUM INTAKE; CONTROLLED STUDY; COPPER DEFICIENCY; DIETARY INTAKE; DUAL ENERGY X RAY ABSORPTIOMETRY; ENDOCRINE DISEASE; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; HYPOGONADISM; HYPOPARATHYROIDISM; HYPOTHYROIDISM; IRAN; MAJOR CLINICAL STUDY; MALE; OSTEOPENIA; OSTEOPOROSIS; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; POPULATION RESEARCH; PUBERTY; QUESTIONNAIRE; SCHOOL CHILD; SHORT STATURE; THALASSEMIA MAJOR; THYROID FUNCTION TEST; VITAMIN BLOOD LEVEL; ZINC DEFICIENCY;

EID: 2442686700     PISSN: 14726823     EISSN: None     Source Type: Journal    
DOI: 10.1186/1472-6823-3-4     Document Type: Article

References (42)

1. Cooley TB and Lee P: A series of cases of splenomegaly in children with anemia and peculiar changes. Trans Am Pediatr Soc 1925, 37:29-30.
2. Saka N, Sukur M, Bundak R, Anak S, Neyzi O and gedikoglu G: Growth and puberty in thalassemia major. J Pediatr Endocrinol Metab 1995, 8:181-186.
3. Modell B, Letsky EA, Flynn DM, Peto R and Weatherall DJ: Survival and desferrioxamine in thalassemia major. BMJ 1982, 284:1081-1084.
4. Jensen CE, Tuck SM, Agnew JE, Koneru S, Morris RW, Morris RW, Yardumian A, Prescott E, Hoffbrand AV and Wonke B: High prevalence of low bone mass in thalassaemia major. B J Haemat 1998, 103:911-915.
5. Vullo C, De Sanctis V, Katz M, Wonke B, Hoffbrand AV, Bagni B, Torresani T, Tolis G, Masiero M, Di Palma A and Borgatti L: Endocrine abnormalities in thalassemia. Ann NY Acad Sci 1990, 612:293-310.
6. Soliman A, Banna N, Abdel Fattah M, ElZalabani MM and Ansari BM: Bone mineral density in prepubertal children with β-thalassemia: correlation with growth and hormonal data. Metabol 1998, 47:541-548.
7. Fuchs GJ, Tienboon P, Linpisarn S, Nimsakul S, Leelapat P, Tovanabutra S, Tubtong V, DeWier M and Suskind RM: Nutritional factors and thalassemia major. Arch Dis Child 1996, 74:224-7.
8. Bashir NA: Serum zinc and copper levels in sickle cell anaemia and beta-thalassaemia in North Jordan. Ann Trop Paediatr 1995, 15:291-3.
9. De Sanctis V and Wonke B: Aetiology of growth retardation in thalassemia major. In Growth in thalassemia, Roma: Mediprint 1994:39.
10. Tanner MM and Whitehouse RH: Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 1976, 51:170-179.
11. Smith JC Jr, Butrimovitz GP and Purdy WC: Direct measurement of zinc in plasma by atomic absorption spectroscopy. Clin Chem 1979, 25:1487-91.
12. Carl A, Burtis Edward R and Ashwood Norbert W: Trace Elements; Methods for determination of Copper. In: Tietz Textbook of Clinical Chemistry Philadelphia: WB Saunders; 1999:984.
13. Cappellini M, Cohen A, Eleftheriou A, Piga A and Porter J: Endocrine Complications in Thalassaemia Major. In: Guidelines for the Clinical Management of Thalassaemia. TIF 2000:41-49.
14. Italian Working Group on Endocrine Complications in Non-Endocrine Diseases: Multicenter study on prevalence of endocrine complication in Thalassemia Major. Clin Endocrinal 1995, 42:581-586.
15. Evered DC, Ormston BJ, Smith PA, Hall R and Bird T: Grade of hypothyroidism. BMJ 1973, 1:657-662.
16. Kwan EY, Lee AC, Li AM, Tam SC, Chan CF, Lau YL and Low LC: A cross-sectional study of growth, puberty and endocrine function in patients with thalassaemia major in Hong Kong. J Paediatr Child Health 1995, 31:83-7.
17. Chern JPC, Lin KH, Lu MY, Lin DT, Lin KS, Chen JD and Fu CC: Abnormal glucose tolerance in transfusion-dependent beta-thalassemic patients. Diabetic care 2001, 24:850-4.
18. Magro S, Puzzanio P, Consarino C, Galati MC, Morgione S, Porcelli D, Grimaldi S, Tancre D, Arcuri V and De Santis V: Hypothyroidism in patients with thalassemia syndromes. Acta Haematol (Basel) 1990, 84:72-6.
19. Sabato AR, De Sanctis V, Atti G, Capra L, Bagni B and Vullo C: Primary hypothyroidism and the low T3 syndrome in thalassemia major. Arch Dis Child 1983, 58:120-7.
20. Depaz G, Deville A, Coussement N, Manassero J and Mariani R: Thyroid function in thalassemia major. Ann Pediatr (Paris) 1985, 32:809-11.
21. Phenekos C, Karamerou A, Pipis P, Constantoulakis M, Lasaridis J, Detsi S and Politou K: Thyroid function in patients with homozygous β-thalassemia. Clin Endocrinol (Oxf) 1984, 20:445-50.
22. Landau H, Matoth I, Landau-Cordova Z, Goldfarb A, Rachmilewitz EA and Glaser B: Cross-sectional and longitudinal study of the pituitary-thyroid axis in patients with thalassaemia major. Clin Endocrinol (Oxf) 1993, 38:55-61.
23. De Sanctis V, Vullo C, Katz M, Wonke B, Hoffbrand VA, Di Palma A and Bagni B: Endocrine complications in thalassemia major. In Advances and Controversies in Thalassemia Therapy Edited by: Buckner CD, Gale RP, Lucarelli G. New York: Alan Liss; 1989:77-83.
24. De Sanctis V and Wonke B: Growth and endocrine complications. In Growth and endocrine complications in thalassemia Roma: Mediprint; 1998:17-30.
25. Flynn DM, Fairney A, Jackson D and Clayton BE: Hormonal changes in thalassemia major. Arch Dis child 1976, 51:828-36.
26. Pignatti CB, De Stefano P, Zonta L, Vullo C, De Sanctis V, Melevendi C, Naselli A, Masera G, Terzoli S, Gabutti V and Piga A: Growth and sexual maturation in thalassemia major. J Pediatr 1985, 106:150-5.
27. Canale VC, Steinherz P, New M and Erlandson M: Endocrine function in thalassemia major [Abstract]. Ann NY Acad Sci 1974, 232:333.
28. Costin G, Kogut M, Hyman CB and Ortega J: Endocrine abnormalities in thalassemia major. Am J Dis Chil 1979, 133:497-502.
29. Suda K: Hemosiderin deposition in the pancreas. Arch Pathol Lab Med 1985, 109:996-999.
30. Masala A, Meloni T, Gallisai D, Alagna S, Rovasio PP, Rassu S and Milia AF: Endocrine functioning in multitransfused prepubertal patients with homozygous beta thalassemia. J Clin Enocrinol Metab 1984, 58:667-70.
31. Zervas A, Katopodi A, Protonotariou A, Livadas S, Karagiorga M, Politis C and Tolis G: Assessment of thyroid function in two hundred patients with beta-thalassemia major. Thyoid 2002, 12:151-4.
32. Olivieri NF, Nathan DG, MacMillan JH, Wayne AS, Liu PP, McGee A, Martin M, Koren G and Cohen AR: Survival in medically treated patients with homozygous β-thalassemia. N Engl J Med 1994, 331:574-578.
33. Molyvda-Athanassopoulou E, Sioundas A, Karatzas N, aggelaki M, Pazaitou K and Vainas I: Bone mineral density of patients with thalassemia major: four-year follow-up. Calcif Tissue Int 1999, 64:481-484.
34. Voskaridou E, Kyrtsonis MC, Terpos E, Skordili M, Theodoropoulos I, Bergele A, Diamanti E, Kalovidouris A, Loutradi A and Loukopoulos D: Bone resorption is increased in young adults with thalassemia major. Br J Haemaol 2001, 112:36-41.
35. Jensen CE, Tuck SM and Agnew JE: High prevalence of low bone mass in thalassemia major. Br J Hematol 1998, 103:911-915.
36. Anapliotou ML, Kastanias IT, Psara P, Evangelou EA, Liparaki M and Dimitriou P: The contribution of hypogonadism to the development of osteoporosis in thalassemia major: new therapeutic approaches. Clin Endocrinol 1995, 42:279-287.
37. Garofalo F, Piga A, Lala R, Chiabotto S, Di Stefano M and Isala GC: Bone metabolism in thalassemia [Abstract]. Ann NY Acad Sci 1998, 850:475-478.
38. Theodoridis C, Ladis V, Papatheodorou A, Berdousi H, Palamidou F, Evagelopoulou C, Athanassaki K, Konstantoura O and Kattamis C: Growth and management of short stature in thalassaemia major. J Pediatr Endocrinol Metab 1998, Suppl 3:835-44.
39. Arcasoy A, Cavdar AO, Ertug H, Gurpinar F, Prasad AS, Cavdar AO, Brewer GJ, Aggett PJ and eds: Zinc deficiency in human subjects. NewYork: Alan R Liss Inc 1983:107-16.
40. Mahmoodi MR and Kimiagar SM: Prevalence of zinc deficiency in junior high school students of Tehran City. Biol Trace Elem Res 2001, 81(2):93-103.
41. Bielinski BK, Darbyshire PJ, Mathers L, Crabtree NJ, Kirk JM, Stirling HF and Shaw NJ: Impact of disordered puberty on bone density in beta thalassemia major. Br J Hematol 2003, 120:353-8.
42. Tsitoura S, Amarilio N, Lapatsani P, Pantelakis S and Doxiadis S: Serum 25 hydroxy vitamin D levels in thalassemia. Arch Dis Child 1978, 53:347.